Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
for
Neoplasm Metastasis, Non-Small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, New York NY, Durham NC,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT04886804
Phase 1, Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Washington D.C. DC, Baltimore MD, Newark DE,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase 2, Recruiting
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
for
Advanced Renal Cell Carcinoma (aRCC),
Location: Washington D.C. DC, Hershey PA, Chapel Hill NC,
Sponsor: Brian Rini
Sex: All
Age: 18+
Code: NCT07188896
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Washington D.C. DC, Richmond VA, Charlottesville VA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Washington D.C. DC, Richmond VA, Columbus OH,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07095465
Phase 3, Recruiting
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
for
Hemorrhage
Location: Washington D.C. DC, Columbus OH, Charlotte NC,
Sponsor: Corza Medical GmbH
Sex: All
Age: 0+
Code: NCT06664775
Phase 3, Recruiting
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
for
Breast Neoplasm Female, Early Detection of Cancer,
Location: Washington D.C. DC
Sponsor: Georgetown University
Sex: Female
Age: 18 - 70+
Code: NCT06892275
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
for
Lewy Body Dementia Psychosis
Location: Washington D.C. DC, Richmond VA, Chapel Hill NC,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 55 - 70+
Code: NCT07029581
Phase 2, Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
for
Agitation, Alzheimer Disease
Location: Washington D.C. DC, Philadelphia PA, Toms River NJ,
Sponsor: Celgene
Sex: All
Age: 55 - 70+
Code: NCT06808984
Phase 2, Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Washington D.C. DC, Bethesda MD, Fairfax VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT06943755
Phase 2, Phase 3, Recruiting
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
for
Familial Adenomatous Polyposis (FAP)
Location: Washington D.C. DC, Baltimore MD, Danville PA,
Sponsor: Rapamycin Holdings Inc.
Sex: All
Age: 18+
Code: NCT06950385
Phase 3, Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
for
Solid Tumors
Location: Washington D.C. DC, Fairfax VA, Philadelphia PA,
Sponsor: ORIC Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05315700
Phase 1, Phase 2, Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for
Locoregional Recurrence,
Location: Washington D.C. DC, Hershey PA, Richmond VA,
Sponsor: Oana Danciu
Sex: All
Age: 18+
Code: NCT05467891
Phase 2, Recruiting
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
for
Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma
Location: Washington D.C. DC, Fairfax VA, Louisville KY,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07407933
Phase 1, Phase 2, Recruiting
Nilotinib in Huntington's Disease
for
Huntington Disease
Location: Washington DC
Sponsor: Georgetown University
Sex: All
Age: 25 - 70+
Code: NCT03764215
Phase 1, Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Washington D.C. DC, Fairfax VA, New York NY,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase 1, Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Washington D.C. DC, Fairfax VA, Pittsburgh PA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase 1, Phase 2, Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumor
Location: Washington D.C. DC, Fairfax VA, East Brunswick NJ,